Search Results for keywords:"misbranding"

The Environmental Protection Agency (EPA) has received a petition from the Attorneys General of several states, asking the agency to change the rules about pesticide labeling requirements. They want the EPA to ensure that no state can have pesticide labels that conflict with the EPA's findings about health risks, like cancer or birth defects, identified during their risk assessments. The public is invited to comment on this petition until February 20, 2025. The EPA is considering modifying its regulations to prevent such inconsistent state labeling from being allowed.

The Food and Drug Administration (FDA) has denied Yong Sheng Jiao's request for a hearing and has banned him from importing or offering to import any drugs into the United States for five years. This decision stems from Jiao's conviction for importing misbranded drugs, specifically dipyrone, by mislabeling them as sebacic acid. Jiao tried to argue that he was not responsible for the misbranding, claiming it was his supplier's fault, but the FDA maintained that his guilty plea in court provided enough basis for the ban. The FDA determined a five-year ban was appropriate after weighing the seriousness of his offense against the few mitigating actions he took.